Every reason to discontinue lithium

Manuel E.Fuentes Salgado; Bruce Sutor; Robert C. Albright; Mark A. Frye

doi:10.1186/s40345-014-0012-y

Every reason to discontinue lithium

Manuel E.Fuentes Salgado
, Bruce Sutor
, Robert C. Albright
, Mark A. Frye

Psychiatry and Psychology

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Abstract

Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.

Original language	English (US)
Article number	12
Pages (from-to)	1-3
Number of pages	3
Journal	International Journal of Bipolar Disorders
Volume	2
Issue number	1
DOIs	https://doi.org/10.1186/s40345-014-0012-y
State	Published - 2014

Keywords

Efficacy
Lithium
Toxicity

ASJC Scopus subject areas

Psychiatry and Mental health
Biological Psychiatry

Access to Document

10.1186/s40345-014-0012-y

Cite this

@article{9a2a75cbdef64b43a5d931477ea849ab,

title = "Every reason to discontinue lithium",

abstract = "Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.",

keywords = "Efficacy, Lithium, Toxicity",

author = "Salgado, \{Manuel E.Fuentes\} and Bruce Sutor and Albright, \{Robert C.\} and Frye, \{Mark A.\}",

note = "Publisher Copyright: {\textcopyright} 2014, Salgado et al.; licensee Springer.",

year = "2014",

doi = "10.1186/s40345-014-0012-y",

language = "English (US)",

volume = "2",

pages = "1--3",

journal = "International Journal of Bipolar Disorders",

issn = "2194-7511",

publisher = "Springer Science and Business Media Deutschland GmbH",

number = "1",

}

TY - JOUR

T1 - Every reason to discontinue lithium

AU - Salgado, Manuel E.Fuentes

AU - Sutor, Bruce

AU - Albright, Robert C.

AU - Frye, Mark A.

PY - 2014

Y1 - 2014

N2 - Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.

AB - Lithium as a gold standard therapy for bipolar disorder is well known to have a number of medical comorbidities that impact renal, parathyroid, and thyroid function. Despite these medical comorbidities, there remains a group of lithium-responsive lithium-treated patients who have maintained mood stability for decades. The risk/benefit ratio of end organ toxicity/mood stability must be evaluated in each individual case.

KW - Efficacy

KW - Lithium

KW - Toxicity

UR - https://www.scopus.com/pages/publications/85012288028

UR - https://www.scopus.com/pages/publications/85012288028#tab=citedBy

U2 - 10.1186/s40345-014-0012-y

DO - 10.1186/s40345-014-0012-y

M3 - Letter

AN - SCOPUS:85012288028

SN - 2194-7511

VL - 2

SP - 1

EP - 3

JO - International Journal of Bipolar Disorders

JF - International Journal of Bipolar Disorders

IS - 1

M1 - 12

ER -

Every reason to discontinue lithium

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this